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The purpose of this letter is solely to raise and emphasize the issue of possible artifacts 
arising from single nucleotide polymorphisms (SNPs) for users of Illumina methylation 
microarrays [1-4].  The authors would like to stress that there is no intention of 
discrediting or criticizing published works by other researchers or Illumina.  
The Illumina Infinium microarray platform (Infinium Methylation 450K; 
Illumina, Inc. CA, USA) is the most widely-used approach for epigenome-wide analysis 
of DNA methylation.  The HumanMethylation450 BeadCheap microarray interrogates 
methylation at >485,000 methylation sites that correspond to approximately 99 % of 
Refseq human genes and 96% of CpG islands [5]. The methylation detection probes on 
the array are 50 nucleotides in length (50-mer) and hybridize bisulfite-converted human 
genomic DNA sequences.  These probes can be of two forms: the first, the Infinium I 
assay, uses separate ³XQPHWK\ODWHG´and ³PHWK\ODWHG´TXHU\SUREHs; while the second, 
the Infinium II assay, represents the ³DOO-or-QRQH´DSSURDFK and utilizes a single probe.  
Further details will not be provided in this letter, but can be found elsewhere [6]. The 50-
mer probes are designed to interrogate a single CpG site that can potentially be 
methylated, at the ¶end of probe.  However, there may also be multiple other CpGs 
within the 50-mer probe.  DNA methylation at the ¶CpG site is measured using 
TXDQWLWDWLYH³JHQRW\SLQJ´RIELVXOILWH-converted genomic DNA.  The bisulfite-conversion 
of DNA results in the deamination of unmethylated cytosines to uracil, leading to the 
incorporation of thymines during subsequent PCR-based amplification, while methylated 
cytosines are protected [7].  Therefore, at known CpG sites a µ&*¶genotype will 
correspond to methylated sites within bisulfite-converted DNA and µ7*¶to unmethylated 
sites.  The level of DNA methylation at a given CpG site is then calculated by the ratio of 
fluorescent intensity (beta value) over the total, M/(M+U); M and U denote the average 
fluorescent signals from the methylated and unmethylated bead types of the probes, 
respectively.   
 
The Infinium methylation microarrays offer the researcher a powerful tool to 
assess DNA methylation across the genome, but the possibility of technical artifacts 
needs to be taken into account, some of which can also be seen with other bisulfite-
conversion-based techniques. In particular, the Infinium probes overlap with positions of 
known DNA variants. Based on the HumanMethylation450 BeadChip manifest file 
(a.k.a. Infinium 450k annotation file), 56% of the probes on the array (273,660 of 
485,512 probes) contain at least one SNP within their 50-mer length [10]. .  In this letter, 
we will discuss the issue of artifacts arising from SNP-associated probes, and how SNPs 
can potentially interfere with the assessment of DNA methylation to different degrees 
within the Infinium array.  
 
Considerations for potential confounding by SNPs 
The potential for confounding of results is dependent upon a number of factors associated 
with the SNP(s). 
1) Type of Alleles: DNA variants can exist in different forms. Cytosine 
methylation has a spontaneous risk of deamination to thymine, thus eliminating the 
potential for the site to be methylated, and this event is more common than would be 
expected by random chance.  If the SNP allele is either C to T or G to A (vice versa) at 
either position within a CpG site, the site may no longer be a candidate for DNA 
methylation.  However, it is not possible to distinguish between changes in DNA 
sequence and changes in DNA methylation within the bisulfite-converted DNA, as a CpG 
to TpG genomic variant cannot be distinguished from an unmethylated cytosine 
following bisulfite conversion. Indeed, if the SNP exists at the C of the target CpG, 
therefore existing as either CG or TG, the DNA methylation array will serve only to 
perform as if a SNP array [4]. In contrast, if the SNP exists at the G of the target CpG, it 
will potentially inhibit the efficiency of hybridization of the bisulfite-converted genomic 
DNA sequences to the probes.  
While interference of hybridization occurs with a variety of types of SNP, it is not 
known whether pyrimidine-pyrimidine (cytosine and thymine) mismatches are as 
problematic as purine-purine (adenine and guanine), as is the case with PCR primer 
annealing [11].  
2) Distance: a SNP can be present anywhere within the 50-mer probe.  The 
Infinium 450k annotation file classifies SNP-associated probes based upon the distance 
between the SNP and the target CpG (only those within 10 bases), on the assumption that 
SNPs closer to the target CpG site present a greater risk of impacting upon accurate 
measurement of methylation level. This issue is especially problematic when the risk of 
beta value variation from SNP artifacts is higher than actual biological variation, as is 
commonly the case with environmental epigenetics studies.  Thus, technical data is 
required to establish the validity of this assumption. 
3) Population diversity: a SNP can present with different frequencies across 
subsections of the human population, with some more prevalent in certain ethnicities than 
in others.  Therefore, it is important to consider the population being studied and to 
utilize data regarding the frequency of SNPs within it, where available [12].   
4) Number of SNPs: a probe may contain multiple SNPs within its sequence. 
Indeed, we have observed some probes to contain more than 16 SNPs (e.g. cg24170212) 
[10].  The number of SNPs within a probe will further impact upon the hybridization 
efficiency, and there is a need for data describing possible synergistic effects of multiple 
SNPs within the probe sequence. 
 
The efficiency of hybridization of the probe is therefore dependent upon a range 
of factors. The impacts of SNPs upon beta values from associated probes are not 
expected to be uniform, and therefore can be difficult to identify.  Some SNP loci clearly 
show binary beta values as would be expected from a SNP array, with beta values of 0.0 
and 1.0 corresponding to the two homozygote genotypes and a value of 0.5 
corresponding to heterozygotes [4].  However, the beta values from most SNP-associated 
probes are less predictable due to the multitude of factors affecting probe hybridization.  
Thus, caution must be taken LQYDOLGDWLQJWKHµWRSKLWV¶, such as the most significantly 
hyper- or hypomethylated loci between experimental groups by ranking, in order to 
determine whether beta values are truly reflecting DNA methylation patterns.   
The impact of potential SNP-induced artifacts from DNA methylation 
microarrays is expected to be much greater within epigenetic epidemiology studies, 
where DNA methylation displays less variation than with cancer epigenetics, for 
example. Where technical variation from SNP loci is greater than biological variation, as 
would be the case with epigenetic epidemiology studies, it is reasonable to expect that 
µWRSKLWV¶PD\FRQWDLQDKLJKHUSUHYDOHQFHRISNP-associated probes than would be 
expected by chance.  
The potential for SNP artifacts on the methylation array can also be 
misinterpreted with the study of mQTLs (methylation quantitative trait loci), regarding 
SNPs whose genotype correlates with DNA methylation. If a SNP occurs in either the C 
or G of the target CG site, the SNP will directly interfere with DNA methylation, rather 
than simply correlate with it. For example, the rs8133082 (G/T) SNP is present within a 
CG site, thereby resulting in a CG or CT genotype. As DNA methylation can only occur 
at CG sites, the T genotype removes the potential for the cytosine to be methylated. 
 
Possible Solutions 
It is therefore important to be stringent when performing the data analysis, in 
order to determine whether beta values truly reflect variation in DNA methylation or 
could be the product of genotype or technical variation resulting from SNPs.  
Subsequently, it is now common to exclude SNP-associated loci in order to limit one 
source of confounding of results.  However, as 56% of the probes on the Infinium array 
contain SNPs [10], it would not be appropriate to remove all SNP-associated probes from 
the analysis process, and therefore consideration must be paid to what parameters should 
be set.  Accounting for the potential confounding by SNPs can be performed a priori, or 
post hoc RILGHQWLI\LQJWKHµWRSKLWV¶ 
 
1) a priori exclusion of SNP-associated loci: the exclusion criteria need to be 
carefully considered and based upon the aforementioned factors.  This is sometimes 
performed, for example, by excluding probes where SNPs are present within 10 bases 
and show a minor allele frequency of more than 5% [3] (or 1% [13]) within the ethnicity 
of the study population.  The identification of significantly different loci is then 
performed having excluded the probes which met these criteria. 
2) post hoc exclusion of SNP-associated loci: as an alternative approach, the 
researcher may opt to carefully review all the top hits using a resource such as dbSNP or 
BLAT search [14], in order account for potential confounding. In the Illumina annotation 
file, the genomic sequence of the probe can be found under the KHDGHUµ6RXUFH6HT¶DORQJ
with the bisulfite sequence of the probe under the headers µ$OOHOH$B3UREH6HT¶DQG
µ$OOHOH%B3UREH6HT¶(depending upon the Infinium probe type).  The genomic sequences 
can then be used to perform a BLAT search in order to identify SNPs within the probe 
sequence. 
 
In addition to taking SNP-associated loci into account during the analysis of the 
microarray data, the researcher may wish to consider further measures to ensure against 
confounding of results.  The verLILFDWLRQRI'1$PHWK\ODWLRQDWWKHµWRSKLWV¶E\DQRWKHU
method, such as pyrosequencing, would serve to inform upon the veracity of the results 
by utilizing approaches that are not as influenced by the presence of SNPs.  It should be 
noted, however, that C/T SNPs directly affecting the cytosine residue of the target CpG 
sites would not be detectable by such methods.  In such cases where a C/T SNP may be 
present, genotyping of the loci, such as by pyrosequencing or Sanger sequencing of 
unconverted genomic DNA would enable clarification. 
SNPs represent a substantial challenge to researchers using microarray platforms, 
but with careful consideration it is possible to determine bona fide differences in DNA 
methylation and overcome confounding induced by SNPs, thereby enabling the 
researcher to utilize this tremendously powerful platform. 
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